Company intelligence / Profile preview

Vitara Biomedical

Philadelphia, Pennsylvania, United Statesvitara.com ↗

Ownership: Private
Employees: ~57
Development stage: Preclinical

Overview

Studies with fetal lambs have shown that the Vitara System can safely support mid-to-late gestation animals for 10–28 days, allowing continued healthy organ development without harm. The company is preparing a first-in-human clinical study. No human clinical results are available yet.

Therapeutic areas: OtherPulmonologyWomen's Health
Modalities: Device (therapeutic medical device)Platform technology (therapeutic platform inspired by natural physiological processes)
Industry: Therapeutic Medical Devices

Partnerships

Children’s Hospital of Philadelphia (CHOP) – originator/collaborator on initial technology developmentStrategic partnerships with healthcare institutions anticipated but not specifically named as formal partners yet

Beyond the preview

Go deeper on Vitara Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitara Biomedical.

Explore the full profile